Хлорамфеникол

Quick links

Choose a section

Quick links to important sections

Advertisements

Хлорамфеникол

Advertisements
Advertisements

Overview of Хлорамфеникол

What is Chloramphenicol?

Chloramphenicol is a broad-spectrum antibiotic that has been used in clinical practice since the late 1940s. It belongs to its own distinct class of antibiotics and is characterized by its relatively simple chemical structure, which allows for efficient synthetic production.

Mechanism of Action

Chloramphenicol works by inhibiting bacterial protein synthesis. It binds to the 50S subunit of the bacterial ribosome, preventing the formation of peptide bonds. This action is primarily bacteriostatic, meaning it stops the growth and reproduction of bacteria rather than killing them outright, although it can be bactericidal against certain highly susceptible species.

Antimicrobial Spectrum

This medication is effective against a wide variety of microorganisms, including:

  • Gram-positive bacteria: Including various strains of staphylococci and streptococci.
  • Gram-negative bacteria: Including Haemophilus influenzae, Salmonella species, and Neisseria meningitidis.
  • Anaerobic bacteria: Both gram-positive and gram-negative anaerobes.
  • Atypical pathogens: Such as Rickettsia, Chlamydia, and Mycoplasma.

Clinical Applications

Due to its specific profile, chloramphenicol is typically reserved for the treatment of serious infections where other, less toxic antibiotics are ineffective or contraindicated. In modern medicine, it is frequently utilized in the following forms:

  • Ophthalmic Preparations: Used for treating bacterial conjunctivitis and other superficial ocular infections.
  • Otic Preparations: Used for bacterial infections of the external ear canal.
  • Systemic Administration: Utilized in specific cases of meningitis, typhoid fever, or rickettsial infections when alternative options are limited.

Pharmacokinetics

When administered systemically, chloramphenicol is well-absorbed and distributes widely throughout the body's tissues and fluids. One of its notable characteristics is its ability to effectively cross the blood-brain barrier, resulting in high concentrations within the cerebrospinal fluid. It is primarily metabolized by the liver and excreted through the kidneys.

Advertisements

What side effects are possible with Хлорамфеникол?

Possible side effects and safety information

Chloramphenicol is associated with specific safety characteristics and adverse reactions documented in official regulatory labeling, primarily concerning the blood and lymphatic systems.

Serious Adverse Reactions and Blood System Effects

The most critical safety concern highlighted in regulatory documents is aplastic anemia, a rare form of irreversible, potentially fatal bone marrow failure that is generally not related to the dose or duration of treatment. Separate from this is the more common, dose-related, and generally reversible bone marrow suppression (e.g., leukopenia or anemia), which typically resolves after the medication is stopped.

Population-Specific Constraints

The drug carries a distinct, serious risk for neonates (newborns) known as Gray Baby Syndrome. This potentially fatal condition involves circulatory collapse and is due to the newborn's immature liver metabolism, which prevents adequate drug clearance. Regulatory documents also advise caution for patients with severe hepatic impairment (liver dysfunction) due to increased risk of drug accumulation and toxicity.

Other Documented Adverse Reactions

Adverse reactions that affect other systems are also documented. Gastrointestinal disorders are common and include nausea, vomiting, and diarrhea. Nervous system disorders may include headache. More significantly, peripheral neuropathy and optic neuritis are officially documented, particularly associated with prolonged administration of the medicine. The drug is contraindicated in individuals with a known history of hypersensitivity or pre-existing bone marrow depression.

Advertisements

Overdose and Emergency Response

The official regulatory documents define the Chloramphenicol overdose profile by documenting specific toxic manifestations and mandated emergency actions, focusing on potentially life-threatening outcomes.

Documented Overdose Presentations

Overdose or excessive serum concentrations (often exceeding 25 mu g/mL) may present with general symptoms such as nausea, vomiting, diarrhea, headache, and mental confusion.

A life-threatening complication, primarily documented in neonates and infants, is the Grey Baby Syndrome (GBS). GBS is characterized by abdominal distension, progressive pallid cyanosis, hypothermia, and flaccidity. This syndrome frequently culminates in irreversible circulatory collapse and a potential fatal outcome. Patients with impaired hepatic or renal function also face an increased risk of toxicity due to impaired drug clearance.

Emergency Response and Management

Upon suspicion of an overdose, patients must seek immediate medical attention or contact emergency services immediately, especially if signs of GBS are observed. The first mandated action is the prompt discontinuation of treatment.

No specific antidote is known for Chloramphenicol overdose. Management is limited to symptomatic and supportive treatment. Procedures such as gastric lavage for recent oral exposure, hemodialysis, or charcoal hemoperfusion may be officially described to hasten drug elimination in severe cases, requiring continuous hospital monitoring.

Advertisements

Therapeutic Uses of Хлорамфеникол

What Хлорамфеникол Treats: Main Uses and Benefits

Хлорамфеникол is generally used in situations involving certain distressing symptoms associated with superficial bacterial infections. This is primarily applied in contexts where additional symptomatic support is needed to address conditions presenting with localized discomfort, such as bacterial conjunctivitis of the eye and certain external ear infections like otitis externa. The medicine is also considered relevant for severe systemic bacterial infections, such as typhoid fever and bacterial meningitis, in situations where alternative options are not considered relevant for the specific circumstances.

The medication may help address symptom clusters that interfere with daily comfort, and is relevant when supportive symptom management is appropriate, especially for acute episodes. It provides support that helps ease the overall symptom burden. It is a relevant option for managing symptoms in specific clinical situations. The use of this medicine contributes to improved comfort during periods of heightened symptoms by working to address the bacterial cause and assisting with maintaining functional stability in critical contexts.

Quick Fact

Support for Symptoms Linked to Inflammatory or Irritative States

Advertisements

Eligibility and Restrictions for Use

Population Eligibility for Chloramphenicol

Official regulatory information strictly defines the patient populations eligible for Chloramphenicol use, primarily due to the risk of serious, irreversible blood disorders and metabolic toxicity.

Absolute Contraindications

Chloramphenicol is contraindicated in specific populations based on official governmental labels:

  • Individuals with a personal or family history of blood dyscrasias, including aplastic anaemia.
  • Patients with a known history of hypersensitivity or previous toxic reaction to the medicine or its components.
  • Premature and newborn infants (systemic administration) are excluded due to the high risk of developing the fatal Gray Syndrome.

Restricted and Conditional Use

Use is limited and conditional for several patient groups, requiring careful consideration but not outright prohibition:

  • Hepatic (Liver) or Renal (Kidney) Impairment: Patients with reduced function require restricted use, often mandating dose reduction and careful monitoring to prevent drug accumulation.
  • Pregnancy and Lactation: Systemic use is generally avoided or not recommended during pregnancy, especially near term, and while breastfeeding. Topical use carries fewer restrictions due to minimal systemic absorption.

Systemic Chloramphenicol is officially reserved only for certain serious, life-threatening bacterial infections when less toxic alternatives are ineffective or unsuitable.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Chloramphenicol's interaction profile is officially documented to involve pharmacokinetic and pharmacodynamic mechanisms that may affect co-administered medicinal products.


Documented Interaction Patterns

Interaction Type (Regulatory Focus) Affected Co-administered Products
Pharmacokinetic Inhibition Phenytoin, Cyclosporine, Tacrolimus, Oral Anticoagulants (e.g., Warfarin)
Pharmacodynamic Antagonism Other Antibiotics (e.g., Clindamycin, Erythromycin, Lincomycin)
Additive Toxicity Bone Marrow Depressants (Myelosuppressive agents)

Official Regulatory Classifications

Co-administration with Chloramphenicol can officially lead to increased plasma concentrations and exposure of drugs such as Phenytoin and Cyclosporine, primarily due to Chloramphenicol's documented role as an inhibitor of certain CYP450 enzymes (e.g., CYP2C19 and CYP3A4). This is classified as a significant pharmacokinetic interaction.

Regulatory labeling establishes a formal contraindication against combining Chloramphenicol with live bacterial vaccines, such as the oral Typhoid vaccine, due to the potential for antimicrobial antagonism of the vaccine's effect. Furthermore, an additive risk of hematological toxicity is documented when used alongside other bone marrow depressant agents.

For the pediatric population (specifically neonates and infants), regulatory documents note a significant interaction where the immature metabolic pathways result in reduced drug clearance and officially elevated systemic exposure, requiring specific cautions.

Advertisements

Mechanism of Action

How Chloramphenicol Works: The Mechanism of Action

ℷ️ Molecular Targeting of the Bacterial Protein Engine

Chloramphenicol's primary mechanistic focus is the bacterial 70S ribosome, specifically the 50S ribosomal subunit. The drug initiates its action by reversibly binding within the Peptidyl Transferase Center (PTC), the enzyme complex responsible for building new proteins. This targeted molecular action contributes to the drug's broad-spectrum antimicrobial activity by engaging a system essential for protein synthesis in susceptible bacterial species.


️ Functional Blockade of Peptide Chain Elongation

By lodging in the PTC, Chloramphenicol acts as a direct inhibitor of the peptidyl transferase enzyme, which catalyzes the formation of peptide bonds. This blockade physically prevents the transfer of the growing protein chain, swiftly suppressing the elongation phase of translation. The resulting physiological effect is the cessation of all protein synthesis, which leads directly to the arrest of bacterial growth and replication.


️ Mechanistic Limitations and Bypass Pathways

The inhibitory action of this ribosomal blockade mechanism is constrained by bacterial countermeasures, most notably the production of the enzyme Chloramphenicol acetyltransferase (CAT). This enzyme chemically inactivates the drug before it can bind its target, preventing the intended inhibition cascade from initiating. Additionally, the functional blockade itself is context-specific, meaning its inhibitory strength can be weaker depending on the specific amino acid sequence being translated at the binding site.

Advertisements

Dosage and Administration Information

How to Use Chloramphenicol: Official Administration Guidelines

Chloramphenicol administration must strictly adhere to the dosing and procedural guidelines established to ensure efficacy and minimize risks.


Administration Routes and Forms

Chloramphenicol is officially available and administered via several routes:

  • Systemic: Oral (Capsules, Suspension) or Intravenous (IV) injection/infusion from reconstituted powder (typically as Chloramphenicol Sodium Succinate).
  • Topical: Ocular (Eye Drops, Ointment) and Otic (Ear Drops).

Standard Dosing and Frequency

For systemic treatment, the dosing is weight-based and interval-dependent to maintain effective blood levels.

Feature Guideline (Systemic)
Standard Daily Dose 50 mg/kg/day
Frequency Administered in 4 divided doses every 6 hours
Oral Intake Best taken on an empty stomach (e.g., 1 hour before or 2 hours after meals)

Procedural and Population Rules

  • IV Preparation: The powder must be reconstituted with an approved sterile diluent before administration as an infusion.
  • Neonatal Dosing: Dosage must be reduced for newborns, especially those under two weeks old, often to 25 mg/kg/day or less, due to their immature metabolism.
  • Impaired Function: Patients with hepatic or renal impairment also require dose adjustment and mandatory monitoring of serum drug concentrations.
  • Duration: Treatment must be continued for the full prescribed course (e.g., typically 8-10 days for typhoid fever after the patient is afebrile).
Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Хлорамфеникол

The research evidence for this medicine is structured across two distinct areas: research exploring its use for serious systemic infections and its use for localized superficial infections. Studies in both areas have monitored different types of patient populations and measured varying outcomes.


Evidence for Use in Systemic Severe Bacterial Infections

The research base for systemic use, such as for typhoid fever and bacterial meningitis, primarily consists of systematic reviews and meta-analyses that aggregate findings from older Randomized Controlled Trials (RCTs). Studies in this area have examined outcomes related to patient survival (mortality) and the frequency of treatment failure. Comparative trials have monitored short-term clinical responses, and some studies report that outcomes, when observed in comparison to newer antibiotics, data show patterns related to measurements of treatment failure or mortality in some trials. Evidence remains limited regarding the medicine's evaluation against contemporary multi-drug resistant organisms, and the evidence quality varies across studies.


Evidence for Use in Localized Superficial Infections

The research for topical forms, such as those used in research exploring its use in conditions like bacterial conjunctivitis of the eye, was evaluated in Randomized Controlled Trials (RCTs). Studies explored outcomes related to physical discomfort, such as the time needed for symptoms to change (clinical cure endpoint), and the rate of microbiological cure. Some RCTs have reported that clinical cure rates may have been not significantly different between the medicine group and the placebo group for certain patients. This data must be viewed in the context of the condition's high rate of spontaneous resolution without intervention. Research continues to explore the implications of emerging resistance in bacteria.


Long-Term Studies and What is Still Uncertain

The majority of studies involving this medicine was evaluated in research exploring short-term symptom changes, meaning follow-up durations were limited. Consequently, long-term effects are not fully established. Limited information is available from large-scale, modern dedicated trials that specifically focused on the use of the systemic form in older adults or patients with other complex conditions. Comparative evidence is lacking for many modern comparisons, and certainty remains low for some long-term outcomes.

Key Studies & References

  1. Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update
  2. Chloramphenicol - Electronic Essential Medicines List (eEML) [Used for second-choice status in meningitis]
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Хлорамфеникол (FAQ)


Q: Is Хлорамфеникол the same thing as a penicillin antibiotic?

No. Official documents classify Chloramphenicol as a Miscellaneous Antibiotic or the defining compound of the Amphenicol-class of antibacterials. Penicillins belong to a different drug class (beta-lactams) and have a distinct mechanism of action.


Q: How quickly does Хлорамфеникол usually start working?

At the molecular level, Chloramphenicol is documented to swiftly halt bacterial protein synthesis, which is its primary function. Official clinical studies often monitor the time required for a full microbiological or clinical cure, and observable changes in symptoms typically occur over several days of treatment.


Q: What happens if I stop using Хлорамфеникол too soon?

Regulatory guidance for this medication and other antibiotics emphasizes that the full prescribed course must be completed. Stopping treatment prematurely increases the risk of the infection returning (therapeutic failure) and may contribute to the emergence of resistant bacteria, which could make the infection more difficult to treat in the future.


Q: Can Хлорамфеникол cause a rash or skin irritation?

Yes, regulatory labeling lists potential Hypersensitivity Reactions. These reactions can include skin changes like macular and vesicular rashes or urticaria (hives). Additionally, dermatitis has been reported in association with the topical forms of the medicine.


Q: Is it normal to feel a stinging sensation after applying the eye drops?

Yes, official guidance from regulatory sources describes a stinging or burning sensation in the eye as a common side effect experienced immediately after application. This sensation is typically reported as short-lived.


Q: Is it available without a prescription in some places?

Regulatory information indicates that in certain jurisdictions, the eye drops and eye ointment preparations may be available for purchase at a pharmacy without a prescription for use in adults and children aged 2 years and over. For children under 2, a prescription is typically required.


Q: Does Хлорамфеникол interact with birth control pills?

While specific interactions may vary, some regulatory-derived data suggest that Chloramphenicol can potentially interfere with the metabolism of certain hormones. This may lead to changes in the blood levels of components like progesterone and estrogen. This potential interaction is mentioned in some regulatory-derived drug-interaction summaries.


Q: Are there any common foods or drinks to avoid while using this medicine?

For the topical forms (eye or ear drops/ointment), regulatory guidance states that you can eat and drink normally. If you are taking the oral form, official guidelines generally recommend that it be taken on an empty stomach.


Q: Is it safe for a pregnant woman to use Хлорамфеникол?

Systemic Chloramphenicol is officially classified in a category where risk to the fetus cannot be ruled out. Official regulatory advice states that the systemic medicine should generally be avoided during pregnancy, especially near term, due to the potential risk of toxicity to the newborn.


Q: Is Хлорамфеникол effective against viral infections?

No. Official regulatory documents confirm that Chloramphenicol is a broad-spectrum antibiotic used to treat a wide range of bacterial infections. It works by interfering with bacterial processes and is not effective against fungi, protozoa, or viruses.


Q: What is 'Gray Baby Syndrome' and is it still a risk with Хлорамфеникол?

Gray Syndrome is a distinct and potentially fatal toxic reaction that occurs in newborns and premature infants, primarily with systemic use. Regulatory documents describe the condition as involving symptoms like abdominal distension, progressive pallid cyanosis (a gray skin color), and cardiovascular collapse. This risk persists due to the newborn's immature liver metabolism, which prevents adequate drug clearance.


Q: Are there different strengths of Хлорамфеникол available?

Yes. The medicine is manufactured in various preparations and strengths. For example, topical forms are available as 0.5% eye drops and 1.0% eye ointment. Systemic preparations (capsules or injections) are also produced in different milligram strengths according to the manufacturer's formulation.


Q: Is there a maximum number of days I should use Хлорамфеникол eye drops?

Yes. Official regulatory information for the topical eye drop form often recommends that the medicine should not be used for more than 5 days at a time, unless a longer course is specified on the prescription. Treatment is typically continued for at least 48 hours after the eye appears normal.


Q: Does using Хлорамфеникол make you sensitive to sunlight?

Regulatory labels do not explicitly list photosensitivity as a common or major reaction. However, the drug is associated with a range of Hypersensitivity Reactions (e.g., rashes), and some adverse event reports have cited cases of sun sensitivity.


Q: Is it okay to wear contact lenses while using Хлорамфеникол?

No. Official procedural guidance for ocular use states that soft contact lenses should be removed during the entire period of treatment. Lenses should not be worn for a period of time, often 24 hours, after the medicine has been completely finished.


Q: What should I know about alcohol and the use of Хлорамфеникол?

Official guidance indicates that it is generally acceptable to drink alcohol while using the topical forms of Chloramphenicol, such as the eye drops or eye ointment. However, official information may contain specific restrictions regarding alcohol consumption when using the systemic (oral or IV) forms.


Q: Can Хлорамфеникол be used for ear infections?

The medicine is officially manufactured and documented in the form of Otic (Ear Drops) preparations. This indicates that it has a documented use for treating certain bacterial infections that affect the ear.


Q: Are there known interactions between Хлорамфеникол and common pain relievers?

While interaction lists focus on specific drug classes, some official and veterinary resources advise caution when using Chloramphenicol alongside Salicylates (such as aspirin). This is due to the potential for interference with the metabolism of certain co-administered drugs.


Q: Is Хлорамфеникол banned in any major regions?

While listed by the World Health Organization as an essential human medicine, official government documents, particularly in the US and several other countries, prohibit its use in food-producing animals. This is done to prevent drug residues in the food chain due to the risk of aplastic anemia in humans.


Q: What does the patient leaflet say about overdose?

Regulatory information typically describes the symptoms associated with high concentrations and toxicity rather than providing overdose advice. Risks described include severe adverse effects on the blood-forming organs and cardiovascular collapse (Gray Syndrome) when high levels of the drug are present in the body.


Q: Do studies suggest that antibiotic resistance is a concern with Хлорамфеникол?

Yes. Official regulatory-derived documents state that concern exists internationally regarding the development of multi-drug resistant bacterial strains that include resistance to Chloramphenicol. This potential for resistance is one of the factors considered when regulating the drug's use.


Q: Is it possible to become resistant to Хлорамфеникол over time?

Studies on antibiotic mechanisms indicate that bacteria can develop resistance by producing the Chloramphenicol acetyltransferase (CAT) enzyme, which chemically inactivates the drug. This is the primary mechanism of resistance observed in bacterial populations against this medicine.


Q: Is it normal for vision to be slightly blurred after using the eye ointment?

Yes. Official guidance advises that blurred vision may occur briefly immediately after applying the eye ointment or eye drops. Official guidance notes this effect and states users should ensure their vision is clear before performing activities requiring visual focus.

Advertisements

How should Хлорамфеникол be stored and disposed of?

Storage and Disposal of Chloramphenicol

Storage requirements for Chloramphenicol are specified based on the individual formulation. Certain products, such as specific eye drops, must be refrigerated at a temperature between 2 C and 8 C and protected from light. Other forms must not be stored above 30 C and generally must not be frozen.

All forms must be kept out of the sight and reach of children and stored in the original, tightly closed container.

Topical solutions like eye drops typically have an in-use shelf-life and must be discarded 28 days after first opening. Any unused or expired Chloramphenicol must be disposed of in accordance with local requirements. The medicine should not be thrown away via wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Хлорамфеникол found in:

A-Z Index: